Le Lézard
Classified in: Health, Covid-19 virus
Subjects: ANW, MRR

Global Non-Animal Alternative Testing Market Predicted to Hit $29,390.20 Million, Growing at 13.0% CAGR from 2021 to 2030 [290-Pages] | Proclaimed by Research Dive


The rising need for animal cruelty-free drug development testing methods is fueling the global non-animal alternative testing market growth. The COVID-19 pandemic has positively impacted the market. The Asia Pacific region is likely to lead the market.

NEW YORK, June 10, 2022 /PRNewswire/ -- Research Dive has added a new report to its offerings titled, "Non-animal alternative testing Testing Market by Technology (Cell Culture Technology, High Throughput Technology, Molecular Imaging, and Omic Technology), Method (Cellular Assay, Biochemical Assay, In Silico, and Ex-vivo), End-user (Pharmaceutical Industry, Cosmetics & Household Products, Diagnostics, Chemical Industry, and Food Industry), and Regional Analysis (North America, Europe, Asia-Pacific, and LAMEA): Global Opportunity Analysis and Industry Forecast, 2021-2030".

Research Dive Logo

The global non-animal alternative testing market is expected to garner $29,390.20 million by 2030, growing at a CAGR of 13.0% from 2021 to 2030. The report delivers comprehensive insights into the current condition and future prospective of the industry by meticulously examining market drivers and restraints, opportunities, major segments, and regions.

Get an Access to a PDF Sample Report of the Non-animal Alternative Testing Market (Including Tables, TOC, and Figures)

Key Segment Findings of the Non-Animal Alternative Testing Market:

The market is segmented based on technology, method, end-user, and region.

Region: North America has an Aggressive Growth rate for Non-animal Alternative Testing Market (Avail Customization)

Non-Animal Alternative Testing Market Dynamics

The key factor fueling the growth of the global non-animal alternative testing market is a significant rise in the demand for drugs and medicines among people due to growing prevalence of various aliments worldwide. In addition, increasing focus of market players on the development of novel products, such as artificial organs, to fulfil the increasing demand for innovative drug testing options for numerous sicknesses, for instance, diabetes, is projected to open doors to innovative opportunities for the market growth in the projected period. However, absence of knowledge about the use and benefits of non-animal alternative testing among drug developers is projected to deter the market growth during the forecast period.

Impact of the COVID-19 Pandemic on the Non-Animal Alternative Testing Market:

The COVID-19 pandemic has made a positive impact on the growth of the global non-animal alternative testing market in 2020. In the pandemic period, the pharmaceutical sector has witnessed a significant rise in the need for medicines, as people became more conscious about their health and well-being. Also, many drug developers refrained from working in wet laboratories and functioning in direct contact of animals and human during pre-clinical drug testing. As a result, the demand for non-animal alternative testing has greatly surged; which is fueling the non-animal alternative testing market growth amidst the pandemic period.

Grow your Business after the COVID-10 Pandemic, Get in touch to schedule your call with our Expert

Top Players of the Non-animal alternative testing Market

The major players of the global non-animal alternative testing market are

1.  Vitrocell Systems GMBH

2.  Biovit

3.  Emulate, Inc.

4.  MB Research Laboratory

5.  Tara Biosystems

6.  Bio- Rad

7.  Evotec

8.  Hurel Corporation

9.  Tissues GmbH

10.  Abbott Laboratories

Numerous business strategies, such as acquisitions, mergers, R&D activities, new product developments, and much more, are implemented by these players to attain a strong position in the global market. For instance, in Secember 2021, the U.S. Food and Drug Administration (FDA), a federal agency of the Department of Health and Human Services, introduced the Innovative Science and Technology Approaches for New Drugs (ISTAND), an experimental program that will aid in reducing and replacing animal testing as part of drug invention.

Moreover, the report offers other key details of leading players such as business tactics, financial performance, and product/service range of these players along with Porter's five forces analysis and SWOT analysis.

More about Non-animal Alternative Testing Market:

Related Top Trending Report Links:

About Research Dive

Research Dive is a market research firm based in Pune, India. Maintaining the integrity and authenticity of the services, the firm provides the services that are solely based on its exclusive data model, compelled by the 360-degree research methodology, which guarantees comprehensive and accurate analysis. With an unprecedented access to several paid data resources, team of expert researchers, and strict work ethic, the firm offers insights that are extremely precise and reliable. Scrutinizing relevant news releases, government publications, decades of trade data, and technical & white papers, Research dive deliver the required services to its clients well within the required timeframe. Its expertise is focused on examining niche markets, targeting its major driving factors, and spotting threatening hindrances. Complementarily, it also has a seamless collaboration with the major industry aficionado that further offers its research an edge.

Contact: 

Mr. Abhishek Paliwal 
Research Dive
30 Wall St. 8th Floor, New York NY 10005
(P) +91-(788)-802-9103 (India)
Toll Free: 1-888-961-4454
E-mail: [email protected] 
Website: https://www.researchdive.com
Blog: https://www.researchdive.com/blog/
LinkedIn: https://www.linkedin.com/company/research-dive/
Twitter: https://twitter.com/ResearchDive
Facebook: https://www.facebook.com/Research-Dive-1385542314927521

Logo: https://mma.prnewswire.com/media/997523/Research_Dive_Logo.jpg 


These press releases may also interest you

at 17:20
The jewelry market size in India is estimated to grow by USD 21.54 billion from 2023-2027, according to Technavio. The market is estimated to grow at a CAGR of 5.54% during the forecast period. Cultural significance of jewelry is driving market...

at 17:05
The global cloud storage services market size is estimated to grow by USD 123.84 billion from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of 19.56% during the forecast period. Growth in data generation is driving...

at 16:45
Riot...

at 16:30
As national politics become increasingly polarized, local communities across the country continue to uphold democratic values through civic participation and service. The Summer 2024 edition of Carnegie Reporter magazine looks at what we can learn...

at 16:20
Flowserve Corporation ("Flowserve") , a leading provider of flow control products and services for the global infrastructure markets, has acquired the intellectual property and in-process R&D related to cryogenic Liquefied Natural Gas (LNG) submerged...

at 16:15
USANA Health Sciences, Inc. today announced financial results for its fiscal second quarter ended June 29, 2024. Key Financial & Operating Results Second quarter net sales were $213 million versus $238 million during Q2 2023. Second quarter...



News published on and distributed by: